Ligand Conformational Bias Drives Enantioselective Modification of a Surface-Exposed Lysine on Hsp90

被引:46
作者
Cuesta, Adolfo [1 ]
Wan, Xiaobo [1 ,2 ]
Burlingame, Alma L. [2 ]
Taunton, Jack [1 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
关键词
INHIBITOR; CANCER;
D O I
10.1021/jacs.9b09684
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Targeted covalent modification of surface-exposed lysines is challenging due to their low intrinsic reactivity and high prevalence throughout the proteome. Strategies for optimizing the rate of covalent bond formation by a reversibly bound inhibitor (k(inact)) typically involve increasing the reactivity of the electrophile, which increases the risk of off-target modification. Here, we employ an alternative approach for increasing k(inact) of a lysine targeted covalent Hsp90 inhibitor, independent of the reversible binding affinity (K-i) or the, intrinsic electrophilicity. Starting with a noncovalent ligand, we appended a chiral, conformationally constrained linker, which orients an arylsulfonyl fluoride to react rapidly and enantioselectively with LysS8 on the surface of Hsp90. Biochemical experiments and high-resolution crystal structures of covalent and noncovalent ligand/Hsp90 complexes provide mechanistic insights into the role of ligand conformation in the observed enantioselectivity. Finally, we demonstrate selective covalent targeting of cellular Hsp90, which results in a prolonged heat shock response despite concomitant degradation of the covalent ligand/Hsp90 complex. Our work highlights the potential of engineering ligand conformational constraints to dramatically accelerate covalent modification of a distal, poorly nucleophilic lysine on the surface of a protein target.
引用
收藏
页码:3392 / 3400
页数:9
相关论文
共 32 条
[1]   Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach [J].
Baggio, Carlo ;
Gambini, Luca ;
Udompholkul, Parima ;
Salem, Ahmed F. ;
Aronson, Alexander ;
Dona, Ada ;
Troadec, Estelle ;
Pichiorri, Flavia ;
Pellecchia, Maurizio .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (14) :6350-6363
[2]   Targeted Covalent Inhibitors for Drug Design [J].
Baillie, Thomas A. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (43) :13408-13421
[3]   Discovery of 1-{(3R,4R)-3[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants [J].
Cheng, Hengmiao ;
Nair, Sajiv K. ;
Murray, Brion W. ;
Almaden, Chau ;
Bailey, Simon ;
Baxi, Sangita ;
Behenna, Doug ;
Cho-Schultz, Sujin ;
Dalvie, Deepak ;
Dinh, Dac M. ;
Edwards, Martin P. ;
Feng, Jun Li ;
Ferre, Rose Ann ;
Gajiwala, Ketan S. ;
Hemkens, Michelle D. ;
Jackson-Fisher, Amy ;
Jalaie, Mehran ;
Johnson, Ted O. ;
Kania, Robert S. ;
Kephart, Susan ;
Lafontaine, Jennifer ;
Lunney, Beth ;
Liu, Kevin K-C. ;
Liu, Zhengyu ;
Matthews, Jean ;
Nagata, Asako ;
Niessen, Sherry ;
Ornelas, Martha A. ;
Orr, Suvi T. M. ;
Pairish, Mason ;
Planken, Simon ;
Ren, Shijian ;
Richter, Daniel ;
Ryan, Kevin ;
Sach, Neal ;
Shen, Hong ;
Smeal, Tod ;
Solowiej, Jim ;
Sutton, Scott ;
Tran, Khanh ;
Tseng, Elaine ;
Vemier, William ;
Walls, Marlena ;
Wang, Shuiwang ;
Weinrich, Scott L. ;
Xin, Shuibo ;
Xu, Haiwei ;
Yin, Min-Jean ;
Zientek, Michael ;
Zhou, Ru .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) :2005-2024
[4]   Structural bioinformatics-based design of selective, irreversible kinase inhibitors [J].
Cohen, MS ;
Zhang, C ;
Shokat, KM ;
Taunton, J .
SCIENCE, 2005, 308 (5726) :1318-1321
[5]   Lysine-Targeted Inhibitors and Chemoproteomic Probes [J].
Cuesta, Adolfo ;
Taunton, Jack .
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88, 2019, 88 :365-381
[6]   Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition [J].
Dalton, Samuel E. ;
Dittus, Lars ;
Thomas, Daniel A. ;
Convery, Maire A. ;
Nunes, Joao ;
Bush, Jacob T. ;
Evans, John P. ;
Werner, Thilo ;
Bantscheff, Marcus ;
Murphy, John A. ;
Campos, Sebastien .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (03) :932-939
[7]   MAPPING HUMAN-BRAIN MONOAMINE OXIDASE-A AND OXIDASE-B WITH C-11 LABELED SUICIDE INACTIVATORS AND PET [J].
FOWLER, JS ;
MACGREGOR, RR ;
WOLF, AP ;
ARNETT, CD ;
DEWEY, SL ;
SCHLYER, D ;
CHRISTMAN, D ;
LOGAN, J ;
SMITH, M ;
SACHS, H ;
AQUILONIUS, SM ;
BJURLING, P ;
HALLDIN, C ;
HARTVIG, P ;
LEENDERS, KL ;
LUNDQVIST, H ;
ORELAND, L ;
STALNACKE, CG ;
LANGSTROM, B .
SCIENCE, 1987, 235 (4787) :481-485
[8]   Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues [J].
Gambini, Luca ;
Baggio, Carlo ;
Udompholkul, Parima ;
Jossart, Jennifer ;
Salem, Ahmed F. ;
Perry, J. Jefferson P. ;
Pellecchia, Maurizio .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (11) :5616-5627
[9]   Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology [J].
Gehringer, Matthias ;
Laufer, Stefan A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (12) :5673-5724
[10]   Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate [J].
Grimster, Neil P. ;
Connelly, Stephen ;
Baranczak, Aleksandra ;
Dong, Jiajia ;
Krasnova, Larissa B. ;
Sharpless, K. Barry ;
Powers, Evan T. ;
Wilson, Ian A. ;
Kelly, Jeffery W. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2013, 135 (15) :5656-5668